Efficacy of Antiviral Therapy in Chronic Hepatitis B Patients With Normal Alanine Aminotransferase: A Systematic Review and Meta-Analysis

Efficacy of Antiviral Therapy in Chronic Hepatitis B Patients With Normal Alanine Aminotransferase: A Systematic Review and Meta-Analysis

Conclusions: CHB patients with normal ALT could benefit from antiviral therapy, and the virological and serological responses were comparable to that of ALT-elevated ones.

Saved in:

Bibliographic Details
Main Authors:	Yuting Diao, Yueying Zeng, Zhihao Huang, Chunfang You
Format:	Article
Language:	English
Published:	Wiley 2025-01-01
Series:	Canadian Journal of Gastroenterology and Hepatology
Online Access:	http://dx.doi.org/10.1155/cjgh/7689981
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Interferon-Based Hepatitis C Antiviral Treatment Outcomes May Be Predicted by Alanine Aminotransferase Levels
by: Erin Kelly, et al.
Published: (2015-01-01)

Treatment response to nucleos(t)ide analogs in chronic hepatitis B with mildly elevated alanine aminotransferase: Letter to the editor on “Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trial”
by: Jian Wang, et al.
Published: (2025-04-01)

Significant histological changes are not rare in indeterminate‐phase chronic hepatitis B patients with hepatitis B e antigen‐negative and normal alanine aminotransferase levels
by: Deliang Huang, et al.
Published: (2023-12-01)

Updated upper limit of normal for serum alanine aminotransferase value in Vietnamese population
by: Nguyen Tien Huy, et al.
Published: (2022-10-01)

Aspartate Aminotransferase to Alanine Aminotransferase Ratio and Arterial Stiffness in Persian Cohort Study
by: Sahar Sobhani, et al.
Published: (2023-04-01)

An Update on the Role of Alanine Aminotransferase in the Detection of Chronic Liver Diseases Relevant to Primary Care
by: Said A. Al-Busafi, et al.
Published: (2025-01-01)

Alanine aminotransferase contributes to hypoxia sensitivity and dormancy in barley seeds
by: Lochlen G. H. Farquharson, et al.
Published: (2025-06-01)

Alanine Aminotransferase Deficiency in a Patient With Hyperferritinemia, Steatosis Hepatis, and Hepatosplenomegaly
by: Alexander Olkus, et al.
Published: (2022-10-01)

LABORATORY PROTOTYPE OF ELECTROCHEMICAL BIOSENSOR FOR THE QUANTITATIVE ANALYSIS OF ALANINE AMINOTRANSFERASE ACTIVITY
by: D.O. MRUGA, et al.
Published: (2025-04-01)

Association between aspartate aminotransferase to alanine aminotransferase ratio and mortality in critically ill patients with end stage renal disease
by: Xiaomin Liang, et al.
Published: (2025-05-01)

Aspartate aminotransferase to alanine aminotransferase ratio and short-term prognosis of patients with type 2 diabetes hospitalized for heart failure
by: Dan Liu, et al.
Published: (2024-10-01)

Association between Alanine Aminotransferase/Aspartate Aminotransferase Ratio (AST/ALT Ratio) and Coronary Artery Injury in Children with Kawasaki Disease
by: Jinxin Wang, et al.
Published: (2020-01-01)

Measurement and purification of Alanine aminotransferase (ALT) enzyme activity in patients with celiac disease
by: Taghreed U. Mohammed, et al.
Published: (2017-09-01)

Alanine aminotransferase and risk of the metabolic syndrome: a linear dose-response relationship.
by: Setor K Kunutsor, et al.
Published: (2014-01-01)

Measurement and purification of Alanine aminotransferase (ALT) enzyme activity in patients with celiac disease
by: Baghdad Science Journal
Published: (2017-09-01)

High immunocompetence in chronic hepatitis patients with normal alanine transaminase levels and and negative hepatitis B e‐antigen for the progression of liver fibrosis
by: Bianqiao Cheng, et al.
Published: (2024-01-01)

Comparative Study of Serum Levels of Gamma-glutamyl Transferase, Aspartate Aminotransferase (AST), Alanine Transaminase (ALT), AST:ALT, and Bilirubin in Patients with Chronic Hepatitis
by: Poonam Jain, et al.
Published: (2023-08-01)

Expert consensus on the adjustment of blood screening strategy for alanine aminotransferase in Chinese blood donors
by: Blood Screening Expert Group, National Center for Clinical Laboratories
Published: (2025-04-01)

Expanding treatment eligibility for chronic hepatitis B: Balancing benefits, limitations, and healthcare access: Correspondence to editorial on “Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trial”
by: Yao-Chun Hsu, et al.
Published: (2025-04-01)

Complex association between alanine aminotransferase activity and mortality in general population: a systematic review and meta-analysis of prospective studies.
by: Zhengtao Liu, et al.
Published: (2014-01-01)

Efficacy and its Predictors of Antiviral Therapy with Nucleos(T)Ide Analogs in Patients with Chronic Hepatitis B
by: T. H. Nguyen, et al.
Published: (2024-04-01)

Serum Alanine Aminotransferase Levels within Normal Range Have Different Associations with Augmentation Index and Other Cardiometabolic Risk Factors in Nondrinkers and Drinkers: A Chinese Community-Based Analysis
by: Shihui Fu, et al.
Published: (2017-01-01)

Evolution of antiviral treatment chronic for hepatitis B, C and D
by: K. V. Zhdanov, et al.
Published: (2014-09-01)

Antiviral therapy and regression of liver fibrosis at chronic hepatitis B
by: D. T. Abdurakhmanov
Published: (2010-02-01)

Utility of the serum alanine aminotransferase to high density lipoprotein cholesterol ratio in evaluating nonalcoholic fatty liver disease and liver fibrosis
by: Yanyan Xuan, et al.
Published: (2025-07-01)

Tips for Hepatologist Referral of Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease with Alanine Aminotransferase Levels ≤ 30 U/L
by: Miwa Kawanaka, et al.
Published: (2025-06-01)

Treatment Response Monitoring of Chronic Hepatitis B Patients using Transient Elastography and Aspartate Aminotransferase-to-Platelet Ratio Index (APRI)
by: Ignatius R Tenggara, et al.
Published: (2017-11-01)

Treatment Response Monitoring of Chronic Hepatitis B Patients using Transient Elastography and Aspartate Aminotransferase-to-Platelet Ratio Index (APRI)
by: Ignatius R Tenggara, et al.
Published: (2017-11-01)

Efficacy of antiviral therapy in the treatment of severe forms of acute hepatitis B
by: E. V. Esaulenko, et al.
Published: (2016-02-01)

Nonalcoholic fatty liver disease with elevated alanine aminotransferase levels is negatively associated with bone mineral density: Cross-sectional study in U.S. adults.
by: Toshihiro Umehara
Published: (2018-01-01)

The Effectiveness of Antiviral Treatments for Patients with HBeAg-Positive Chronic Hepatitis B: A Bayesian Network Analysis
by: Zhang Hao, et al.
Published: (2018-01-01)

Which of the following tests aspartate aminotransferase, alanine transaminase and alkaline phosphatase, can predict poor outcomes in Coronavirus 2019 patients? a retrospective cohort study
by: Pouyan Ebrahimi, et al.
Published: (2024-05-01)

The influence of hepatic steatosis on the success of antiviral therapy for chronic hepatitis C
by: Preveden Tomislav, et al.
Published: (2017-01-01)

SELECTING THE MANAGEMENT OF PATIENTS WITH CHRONIC HEPATITIS B AFTER THE COMPLETION OF THE LONG-TERM ANTIVIRAL THERAPY
by: E. V. Esaulenko, et al.
Published: (2018-10-01)

Direct Acting Antivirals for the Treatment of Chronic Viral Hepatitis
by: Peter Karayiannis
Published: (2012-01-01)

Construction and validation of a nomogram prediction model for antiviral efficacy based on clinical characteristics and intestinal microflora distribution in patients with chronic hepatitis B
by: Hongjie Wu, et al.
Published: (2025-06-01)

Impact of Hepatic Steatosis on the Antiviral Effects of PEG-IFNα-2a in Patients with Chronic Hepatitis B and the Associated Mechanism
by: Huiqing Liang, et al.
Published: (2020-01-01)

Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection.
by: Dimitra Peppa, et al.
Published: (2010-12-01)

Correction: Watanabe et al. Pemafibrate Improves Alanine Aminotransferase Levels Independently of Its Lipid-Lowering Effect. <i>Livers</i> 2023, <i>3</i>, 562–568
by: Azuma Watanabe, et al.
Published: (2025-02-01)

Iron metabolism in chronic hepatitis C patients on antiviral treatment
by: K. V. Zhdanov, et al.
Published: (2014-09-01)